Article Details

Celltrion's Monoclonal Antibody Treatment for COVID-19, regdanvimab (CT-P59), Demonstrates ...

Retrieved on: 2021-07-16 05:26:15

Tags for this article:

Click the tags to see associated articles and topics

Celltrion's Monoclonal Antibody Treatment for COVID-19, regdanvimab (CT-P59), Demonstrates .... View article details on hiswai:

Excerpt

Celltrion's Monoclonal Antibody Treatment for COVID-19, regdanvimab (CT-P59), Demonstrates Strong Neutralising Activity Against Delta Variant.

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up